FindTrial
Sign In

To study the effect of early integration of supportive care along with chemotherapy in hepatobiliary cancers: a randomised controlled trial

Effect of early integration of palliative care with standard treatment in patients of hepatobiliary cancers: A Randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075157
Enrollment
270
Registered
2024-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C248- Malignant neoplasm of overlappingsites of biliary tract

Interventions

Intervention1: providing specialist palliative care in liaison with oncology team to hepatobiliary cancers patients at first point of presentation to a tertiary care cancer centre.: palliative care ma

Sponsors

DR BRA IRCH AIIMS NEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A. All the patients aged more than18 years; B. All the patients with performance status of 0–3 on the (ECOG performance status) scale; C. All the patients newly diagnosed with hepatobiliary cancers (all stages); D. All the patients who understands Hindi/English.

Exclusion criteria

Exclusion criteria: A. Age below 18 years B. All the patients on ongoing palliative care/ or on Best supportive care; C. Presence of dementia, agitation, or delirium or mental disorder D. Terminally ill patients with PS greater than 3; E. Patients not consenting for the study; F. Patients on prior treatment for hepatobiliary cancers; G. Patients unable to read & write (Hindi/English).

Design outcomes

Primary

MeasureTime frame
To assess the effect of early best supportive care on symptom burden and QoL at 0,1 & 2months in patients with hepatobiliary cancers coming for treatment in a tertiary care center in India.Timepoint: 0,1,2 MONTHS—

Secondary

MeasureTime frame
To assess symptom burden in patients of hepatobiliary cancers coming for treatment in a tertiary care center in India on follow ups using ESAS, EORTC QLQ-C30 & EORTC BIL 21 scores.Timepoint: 0,1,2 MONTHS—

Countries

India

Contacts

Public ContactDr Shweta Bhopale

All India Institute Of Medical Sciences, New Delhi

dr.shwetabhopale06@gmail.com8178188976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026